Education Archive

Broad spectrum HPV vaccine on the way

The May 20th issue of the Journal of the National Cancer Institute reports a study in which mice and rabbits immunized with a multimeric-L2 protein HPV vaccine had robust antibody responses and were protected from infection with HPV16 four months after vaccination.The authors claim that clinical studies in humans are now warranted to assess the safety and immunogenicity of multitype L2 vaccines.